AEMD
Income statement / Annual
Last year (2024), Aethlon Medical, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Aethlon Medical, Inc.'s net income was -$12.21 M.
See Aethlon Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$0.00 |
$574,245.00 |
$294,165.00 |
$659,104.00 |
$650,187.00 |
$229,625.00 |
$149,625.00 |
$392,073.00 |
$886,572.00 |
$762,417.00 |
| Cost of Revenue |
$359,057.00
|
$265,300.00
|
$154,217.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$359,057.00
|
$308,945.00
|
$139,948.00
|
$659,104.00
|
$650,187.00
|
$229,625.00
|
$149,625.00
|
$392,073.00
|
$886,572.00
|
$762,417.00
|
| Gross Profit Ratio |
0
|
0.54
|
0.48
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$2.75 M
|
$2.34 M
|
$2.07 M
|
$927,000.00
|
$896,000.00
|
$586,000.00
|
$673,000.00
|
$782,000.00
|
$1.03 M
|
| General & Administrative Expenses |
$7.43 B
|
$7.51 M
|
$5.69 M
|
$4.90 M
|
$4.10 M
|
$2.98 M
|
$2.21 M
|
$2.86 M
|
$3.04 M
|
$2.31 M
|
| Selling & Marketing Expenses |
-$7.42 B
|
$4.96 M
|
$5.03 M
|
$3.65 M
|
$2.48 M
|
$3.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.76 M
|
$12.47 M
|
$10.72 M
|
$8.55 M
|
$6.58 M
|
$6.23 M
|
$4.98 M
|
$6.49 M
|
$5.27 M
|
$4.76 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$12.28 M
|
$12.62 M
|
$10.72 M
|
$8.55 M
|
$6.98 M
|
$6.23 M
|
$5.49 M
|
$7.39 M
|
$5.27 M
|
$7.30 M
|
| Cost And Expenses |
$12.64 M
|
$12.62 M
|
$10.72 M
|
$8.55 M
|
$6.98 M
|
$6.23 M
|
$5.49 M
|
$7.39 M
|
$5.27 M
|
$7.30 M
|
| Interest Income |
$0.00
|
$10,973.00
|
$0.00
|
$0.00
|
$54,232.00
|
$220,487.00
|
$361,597.00
|
$304,330.00
|
$573,782.00
|
$440,276.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$1,580.00
|
$54,232.00
|
$220,487.00
|
$361,597.00
|
$276,689.00
|
$429,099.00
|
$322,129.00
|
| Depreciation & Amortization |
$359,057.00
|
$240,892.00
|
$123,685.00
|
$39,939.00
|
$26,366.00
|
$30,695.00
|
$35,658.00
|
$32,413.00
|
$38,524.00
|
$37,352.00
|
| EBITDA |
-$11.85 M |
-$11.66 M |
-$10.30 M |
-$7.85 M |
-$6.30 M |
-$5.97 M |
-$5.30 M |
-$6.97 M |
-$4.35 M |
-$6.50 M |
| EBITDA Ratio |
0
|
-20.3
|
-35
|
-11.91
|
-9.08
|
-25.99
|
-32.05
|
-15.47
|
-4.9
|
-5.19
|
| Operating Income Ratio |
0
|
-20.72
|
-35.43
|
-11.97
|
-9.12
|
-26.13
|
-32.29
|
-15.55
|
-4.95
|
-5.24
|
| Total Other Income/Expenses Net |
$428,394.00
|
-$131,148.00
|
$0.00
|
$0.00
|
-$450,053.00
|
-$220,487.00
|
-$868,721.00
|
-$1.21 M
|
-$573,782.00
|
-$2.99 M
|
| Income Before Tax |
-$12.21 M
|
-$12.03 M
|
-$10.42 M
|
-$7.89 M
|
-$6.38 M
|
-$6.22 M
|
-$5.70 M
|
-$7.31 M
|
-$4.96 M
|
-$6.98 M
|
| Income Before Tax Ratio |
0
|
-20.95
|
-35.43
|
-11.97
|
-9.81
|
-27.09
|
-38.09
|
-18.64
|
-5.59
|
-9.15
|
| Income Tax Expense |
$3.00
|
$0.00
|
-$4,799.00
|
-$6,369.00
|
-$6,093.00
|
-$24,785.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$12.21 M
|
-$12.03 M
|
-$10.42 M
|
-$7.89 M
|
-$6.37 M
|
-$6.19 M
|
-$5.68 M
|
-$7.28 M
|
-$4.87 M
|
-$6.80 M
|
| Net Income Ratio |
0
|
-20.95
|
-35.41
|
-11.97
|
-9.8
|
-26.98
|
-37.96
|
-18.56
|
-5.5
|
-8.92
|
| EPS |
-4.86 |
-5.86 |
-7.06 |
-6.52 |
-18.67 |
-51.27 |
-69.17 |
-140.57 |
-98.85 |
-182.25 |
| EPS Diluted |
-4.86 |
-5.86 |
-7.06 |
-6.52 |
-18.67 |
-51.27 |
-69.17 |
-140.57 |
-98.85 |
-182.25 |
| Weighted Average Shares Out |
$2.51 M
|
$2.05 M
|
$1.48 M
|
$1.21 M
|
$341,484.00
|
$120,831.00
|
$82,114.00
|
$51,762.00
|
$49,291.00
|
$37,296.00
|
| Weighted Average Shares Out Diluted |
$2.51 M
|
$2.05 M
|
$1.48 M
|
$1.21 M
|
$341,484.00
|
$120,831.00
|
$82,114.00
|
$51,762.00
|
$49,291.00
|
$37,296.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
